Capricor Therapeutics, Inc.
Undisclosed program
Countdown
358days
Approval decision · ~ Jun 30, 2027 estimated
What's at stake
A final FDA approval decision on Undisclosed program for its lead indication is expected ~ Jun 30, 2027.
Primary source
· SEC 8-K
verified 15h ago
“full facility validation and FDA approval targeted for the first half of 2027.”